Sexual and reproductive health
Kisspeptin-54
Also called Metastin
per administration
A human trial worked out how much to take and how often, so a dosing schedule is shown.
The human evidence for Kisspeptin-54 used the intravenous route. The draw worked out here assumes a subcutaneous injection, so the amount is not a direct read-across.
Work out your draw
These numbers are a starting point — change any of them.
- Concentration
- 1.67mg/mL
- Volume per draw
- 0.06mL
- Units to dial
- 6
- Doses per cartridge
- 50
Vial label
Copy this into your label printer.
Published research contexts for Kisspeptin-54 describe 100–400 mcg per administration. Descriptive only, not a recommendation.
About 20–30 minutes; the decay chart is largely illustrative here.
Human studies delivered kisspeptin-54 by intravenous infusion to probe gonadotropin release; no subcutaneous schedule is established, so no schedule table is shown.
Modelled level — 3x per week
1× is the peak after a single dose.
- Steady-state peak
- 1.00× single dose
- Time to steady state
- 3hours
- Administrations
- 3/ week
Read off the modelled curve, not an even-interval formula
About five half-lives
Where these numbers come from
- Kisspeptin-54 reproductive-axis studies (Dhillo group)Intravenous kisspeptin-54 infusions were used to stimulate gonadotropin secretion in volunteers.